<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39527314</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2584</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Nov</Month><Day>11</Day></PubDate></JournalIssue><Title>International urology and nephrology</Title><ISOAbbreviation>Int Urol Nephrol</ISOAbbreviation></Journal><ArticleTitle>Identifying influencing factors and constructing a prediction model for long COVID-19 in hemodialysis patients.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11255-024-04276-2</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This study aimed to identify the potential influencing factors and construct a prediction model for long COVID in hemodialysis patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively reviewed 115 patients undergoing hemodialysis in a tertiary hospital between December 2022 and January 2023. Both univariate and multivariate logistic regression models were applied to identify potential influencing factors, and the prediction model was constructed using an ROC curve.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 115 included patients, 60 experienced long COVID, with a prevalence of 52.2%. The univariate analysis found that a three-dose COVID-19 vaccination was associated with a reduced risk of long COVID (OR: 0.10; 95%CI: 0.01-0.86; P&#x2009;=&#x2009;0.036). However, severe COVID (OR: 9.49; 95%CI: 1.14-78.90; P&#x2009;=&#x2009;0.037), undergoing CT examination (OR: 3.01; 95%CI: 1.34-6.78; P&#x2009;=&#x2009;0.008), and abnormal neutrophil (OR: 5.95; 95%CI: 1.26-28.19; P&#x2009;=&#x2009;0.025), and platelet (OR: 2.39; 95%CI: 1.11-5.13; P&#x2009;=&#x2009;0.025) counts were associated with a higher risk of long COVID. After adjusting for potential confounding factors, undergoing CT examination (OR: 2.60; 95%CI: 1.02-6.64; P&#x2009;=&#x2009;0.046) and having abnormal neutrophil (OR: 8.16; 95%CI: 1.57-42.38; P&#x2009;=&#x2009;0.013) and monocyte (OR: 17.77; 95%CI: 1.30-242.29; P&#x2009;=&#x2009;0.031) counts were associated with a higher risk of long COVID. The prediction model constructed based on these factors showed a relatively better predictive value (AUC: 0.738; 95%CI: 0.648-0.828; P&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The risk of long COVID-19 in hemodialysis patients was significantly related to undergoing CT examination and having abnormal neutrophil and monocyte counts, and the prediction model constructed using these factors showed a moderate predictive value.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ding</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Air Force Medical Center, PLA, Fucheng Road No.30, Haidian District, Beijing, 100037, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xinlun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Air Force Medical Center, PLA, Fucheng Road No.30, Haidian District, Beijing, 100037, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Chang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Air Force Medical Center, PLA, Fucheng Road No.30, Haidian District, Beijing, 100037, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Wangyan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Air Force Medical Center, PLA, Fucheng Road No.30, Haidian District, Beijing, 100037, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lou</LastName><ForeName>Linjing</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Air Force Medical Center, PLA, Fucheng Road No.30, Haidian District, Beijing, 100037, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Zhuo</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Air Force Medical Center, PLA, Fucheng Road No.30, Haidian District, Beijing, 100037, China. gaozhuo0513@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int Urol Nephrol</MedlineTA><NlmUniqueID>0262521</NlmUniqueID><ISSNLinking>0301-1623</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Factors</Keyword><Keyword MajorTopicYN="N">Hemodialysis</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">Prediction model</Keyword></KeywordList><CoiStatement><b>Declarations</b> <b>Conflict of interests</b> The authors declare no competing interests. <b>Ethics approval and consent to participate</b> The Institutional Review Board of the Air Force Specialized Medical Center approved this study (2023&#x2013;88-PJ01), and informed consent was waived by the committee because of the retrospective nature of the study. <b>Consent for publication</b> Not applicable.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>13</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>13</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>11</Day><Hour>12</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39527314</ArticleId><ArticleId IdType="doi">10.1007/s11255-024-04276-2</ArticleId><ArticleId IdType="pii">10.1007/s11255-024-04276-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 . Accessed at November 15th, 2023.</Citation></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN (2021) Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open 4(5):e2111417. https://doi.org/10.1001/jamanetworkopen.2021.11417</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId><ArticleId IdType="pmc">8155823</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV (2022) A clinical case definition of post-COVID-19 condition by a delphi consensus. Lancet Infect Dis 22(4):e102&#x2013;e107. https://doi.org/10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS et al (2021) Post-acute COVID-19 syndrome. Nat Med 27(4):601&#x2013;615. https://doi.org/10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId><ArticleId IdType="pmc">8893149</ArticleId></ArticleIdList></Reference><Reference><Citation>Gansevoort RT, Hilbrands LB (2020) CKD is a key risk factor for COVID-19 mortality. Nat Rev Nephrol 16(12):705&#x2013;706. https://doi.org/10.1038/s41581-020-00349-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-020-00349-4</ArticleId><ArticleId IdType="pubmed">32848205</ArticleId><ArticleId IdType="pmc">7447963</ArticleId></ArticleIdList></Reference><Reference><Citation>Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant. 2021. https://doi.org/10.1093/ndt/gfaa314</Citation></Reference><Reference><Citation>Cai R, Zhang J, Zhu Y, Liu L, Liu Y, He Q (2021) Mortality in chronic kidney disease patients with COVID-19: a systematic review and meta-analysis. Int Urol Nephrol 53(8):1623&#x2013;1629. https://doi.org/10.1007/s11255-020-02740-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-020-02740-3</ArticleId><ArticleId IdType="pubmed">33389508</ArticleId><ArticleId IdType="pmc">7778685</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikizler TA (2020) COVID-19 and dialysis units: what do we know now and what should we do? Am J Kidney Dis 76(1):1&#x2013;3. https://doi.org/10.1053/j.ajkd.2020.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2020.03.008</ArticleId><ArticleId IdType="pubmed">32217082</ArticleId><ArticleId IdType="pmc">7146661</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilbrands LB, Duivenvoorden R, Vart P, Franssen CFM, Hemmelder MH, Jager KJ et al (2020) COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration. Nephrol Dial Transplant 35(11):1973&#x2013;1983. https://doi.org/10.1093/ndt/gfaa261</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfaa261</ArticleId><ArticleId IdType="pubmed">33151337</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21(3):133&#x2013;146. https://doi.org/10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId><ArticleId IdType="pmc">9839201</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A et al (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 11(1):16144. https://doi.org/10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId><ArticleId IdType="pmc">8352980</ArticleId></ArticleIdList></Reference><Reference><Citation>da Costa E, Silva GR, Moura W&#xc9;A, Dos Santos KC, Gomes DO, Bandeira GN, Guimar&#xe3;es RA et al (2023) Long-term symptoms after mild coronavirus disease in healthy healthcare professionals: a 12-month prospective cohort study. Int J Environ Res Public Health 20(2):1483. https://doi.org/10.3390/ijerph20021483</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20021483</ArticleId></ArticleIdList></Reference><Reference><Citation>Och A, Tylicki P, Polewska K, Puchalska-Regli&#x144;ska E, Parczewska A, Szabat K et al (2021) Persistent post-COVID-19 syndrome in hemodialyzed patients-a longitudinal cohort study from the North of Poland. J Clin Med. https://doi.org/10.3390/jcm10194451</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10194451</ArticleId><ArticleId IdType="pubmed">34640471</ArticleId><ArticleId IdType="pmc">8509624</ArticleId></ArticleIdList></Reference><Reference><Citation>Corr&#xea;a HL, Deus LA, Ara&#xfa;jo TB, Reis AL, Amorim CEN, Gadelha AB et al (2022) Phosphate and IL-10 concentration as predictors of long-covid in hemodialysis patients: A Brazilian study. Front Immunol 13:1006076. https://doi.org/10.3389/fimmu.2022.1006076</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1006076</ArticleId><ArticleId IdType="pubmed">36248863</ArticleId><ArticleId IdType="pmc">9562993</ArticleId></ArticleIdList></Reference><Reference><Citation>Chancharoenthana W, Kamolratanakul S, Leelahavanichkul A, Ariyanon W, Chinpraditsuk S, Saelim R et al (2023) Gastrointestinal manifestations of long-term effects after COVID-19 infection in patients with dialysis or kidney transplantation: An observational cohort study. World J Gastroenterol 29(19):3013&#x2013;3026. https://doi.org/10.3748/wjg.v29.i19.3013</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v29.i19.3013</ArticleId><ArticleId IdType="pubmed">37274795</ArticleId><ArticleId IdType="pmc">10237091</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, Boyton RJ (2023) The immunology of long COVID. Nat Rev Immunol 23(10):618&#x2013;634. https://doi.org/10.1038/s41577-023-00904-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00904-7</ArticleId><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Moga E, Lynton-Pons E, Domingo P (2022) The robustness of cellular immunity determines the fate of sars-cov-2 infection. Front Immunol 13:904686. https://doi.org/10.3389/fimmu.2022.904686</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.904686</ArticleId><ArticleId IdType="pubmed">35833134</ArticleId><ArticleId IdType="pmc">9271749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahlert CR, Strahm C, G&#xfc;sewell S, Cusini A, Brucher A, Goppel S et al (2023) Post-acute sequelae after severe acute respiratory syndrome coronavirus 2 infection by viral variant and vaccination status: a multicenter cross-sectional study. Clin Infect Dis 77(2):194&#x2013;202. https://doi.org/10.1093/cid/ciad143</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad143</ArticleId><ArticleId IdType="pubmed">36905145</ArticleId><ArticleId IdType="pmc">10371307</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Vetter P, Chappuis F, Kaiser L, Guessous I (2023) Prevalence of post-coronavirus disease condition 12 weeks after omicron infection compared with negative controls and association with vaccination status. Clin Infect Dis 76(9):1567&#x2013;1575. https://doi.org/10.1093/cid/ciac947</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac947</ArticleId><ArticleId IdType="pubmed">36519381</ArticleId></ArticleIdList></Reference><Reference><Citation>Joris M, Pincemail J, Colson C, Joris J, Calmes D, Cavalier E et al (2022) Exercise limitation after critical versus mild COVID-19 infection: a metabolic perspective. J Clin Med. https://doi.org/10.3390/jcm11154322</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11154322</ArticleId><ArticleId IdType="pubmed">35893413</ArticleId><ArticleId IdType="pmc">9332476</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemente I, Sinatti G, Cirella A, Santini SJ, Balsano C (2022) Alteration of inflammatory parameters and psychological post-traumatic syndrome in long-COVID patients. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph19127103</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19127103</ArticleId><ArticleId IdType="pubmed">36498327</ArticleId><ArticleId IdType="pmc">9739332</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassler K, Schulte-Schrepping J, Warnat-Herresthal S, Aschenbrenner AC, Schultze JL (2019) The myeloid cell compartment-cell by cell. Annu Rev Immunol 37:269&#x2013;293. https://doi.org/10.1146/annurev-immunol-042718-041728</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042718-041728</ArticleId><ArticleId IdType="pubmed">30649988</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilliams M, Mildner A, Yona S (2018) Developmental and functional heterogeneity of monocytes. Immunity 49(4):595&#x2013;613. https://doi.org/10.1016/j.immuni.2018.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.10.005</ArticleId><ArticleId IdType="pubmed">30332628</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoll R, Schultze JL, Schulte-Schrepping J (2021) Monocytes and Macrophages in COVID-19. Front Immunol 12:720109. https://doi.org/10.3389/fimmu.2021.720109</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.720109</ArticleId><ArticleId IdType="pubmed">34367190</ArticleId><ArticleId IdType="pmc">8335157</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J et al (2020) Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med 26(6):842&#x2013;844. https://doi.org/10.1038/s41591-020-0901-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0901-9</ArticleId><ArticleId IdType="pubmed">32398875</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N, Jiang C, Cai P, Shen Z, Sun W, Xu H et al (2021) Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes. Cell Rep 37(1):109793. https://doi.org/10.1016/j.celrep.2021.109793</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109793</ArticleId><ArticleId IdType="pubmed">34587478</ArticleId><ArticleId IdType="pmc">8445774</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann ER, Menon M, Knight SB, Konkel JE, Jagger C, Shaw TN et al (2020) Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19. Sci Immunol. https://doi.org/10.1126/sciimmunol.abd6197</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd6197</ArticleId><ArticleId IdType="pubmed">32943497</ArticleId><ArticleId IdType="pmc">7857390</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreuter M, Lee JS, Tzouvelekis A, Oldham JM, Molyneaux PL, Weycker D et al (2021) Monocyte count as a prognostic biomarker in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 204(1):74&#x2013;81. https://doi.org/10.1164/rccm.202003-0669OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202003-0669OC</ArticleId><ArticleId IdType="pubmed">33434107</ArticleId><ArticleId IdType="pmc">8437112</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott MKD, Quinn K, Li Q, Carroll R, Warsinske H, Vallania F et al (2019) Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study. Lancet Respir Med 7(6):497&#x2013;508. https://doi.org/10.1016/S2213-2600(18)30508-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(18)30508-3</ArticleId><ArticleId IdType="pubmed">30935881</ArticleId><ArticleId IdType="pmc">6529612</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>